Monoamine oxidase-A and B activities in the cerebellum and frontal cortex of children and young adults with autism

Journal of Neuroscience Research

Volumn 95, Issue 10, 2017, Pages 1965-1972

  Gu, Feng ^a   Chauhan, Ved ^a   Chauhan, Abha ^a  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

autism; MAOA; MAOB; monoamine oxidases (MAOs); oxidative stress; serotonin

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; NEUROTRANSMITTER; SEROTONIN; AMINE OXIDASE (FLAVIN CONTAINING); MONOAMINE OXIDASE A, HUMAN;

ADOLESCENT; ADULT; ARTICLE; AUTISM; CEREBELLUM; CHILD; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FRONTAL CORTEX; HUMAN; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; REFERENCE VALUE; SCHOOL CHILD; YOUNG ADULT; BRAIN CHEMISTRY; ENZYMOLOGY; FRONTAL LOBE; METABOLISM;

ADOLESCENT; AUTISTIC DISORDER; BRAIN CHEMISTRY; CEREBELLUM; CHILD; CHILD, PRESCHOOL; FEMALE; FRONTAL LOBE; HUMANS; MALE; MONOAMINE OXIDASE; YOUNG ADULT;

EID: 85011708032     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.24027     Document Type: Article

References (50)

1. Baron M, Levitt M, Perlman R. 1980. Low platelet monoamine oxidase activity: a possible biochemical correlate of borderline schizophrenia. Psychiatry Res 3:329–335.
2. Bortolato M, Shih JC. 2011. Behavioral outcomes of monoamine oxidase deficiency: preclinical and clinical evidence. Int Rev Neurobiol 100:13–42.
3. Bortolato M, Godar SC, Alzghoul L, Zhang J, Darling RD, Simpson KL, Bini V, Chen K, Wellman CL, Lin RC, et al. 2013. Monoamine oxidase A and A/B knockout mice display autistic-like features. Int J Neuropsychopharmacol 16:869–888.
4. Brunner HG, Nelen M, Breakefield XO, Ropers HH, Van Oost BA. 1993. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science 262:578–580.
5. Cases O, Seif I, Grimsby J, Gaspar P, Chen K, Pournin S, Muller U, Aguet M, Babinet C, Shih JC. 1995. Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA. Science 268:1763–1766.
6. Cases O, Lebrand C, Giros B, Vitalis T, De Maeyer E, Caron MG, Price DJ, Gaspar P, Seif I. 1998. Plasma membrane transporters of serotonin, dopamine, and norepinephrine mediate serotonin accumulation in atypical locations in the developing brain of monoamine oxidase A knock-outs. J Neurosci 18:6914–6927.
7. Chauhan A, Chauhan V. 2006. Oxidative stress in autism. Pathophysiology. 13:171–181.
8. Chauhan A, Chauhan V, Brown WT, editors. 2009. Autism: oxidative stress, inflammation and immune abnormalities. Boca Raton (FL): CRC Press/Taylor and Francis.
9. Chauhan A, Gu F, Essa MM, Wegiel J, Kaur K, Brown WT, Chauhan V. 2011. Brain region-specific deficit in mitochondrial electron transport chain complexes in children with autism. J Neurochem 117:209–220.
10. Chauhan A, Audhya T, Chauhan V. 2012a. Brain region-specific glutathione redox imbalance in autism. Neurochem Res 37:1681–1689.
11. Chauhan A, Gu F, Chauhan V. 2012b. Mitochondrial respiratory chain defects in autism and other neurodevelopmental disorders. J Pediatr Biochem 2:213–223.
12. Chen K, Holschneider DP, Wu W, Rebrin I, Shih JC. 2004. A spontaneous point mutation produces monoamine oxidase A/B knock-out mice with greatly elevated monoamines and anxiety-like behavior. J Biol Chem 279:39645–39652.
13. Cohen IL, Liu X, Schutz C, White BN, Jenkins EC, Brown WT, Holden JJ. 2003. Association of autism severity with a monoamine oxidase A functional polymorphism. Clin Genet 64:190–197.
14. Cohen IL, Liu X, Lewis ME, Chudley A, Forster-Gibson C, Gonzalez M, Jenkins EC, Brown WT, Holden JJ. 2011. Autism severity is associated with child and maternal MAOA genotypes. Clin Genet 79:355–362.
15. Davis LK, Hazlett HC, Librant AL, Nopoulos P, Sheffield VC, Piven J, Wassink TH. 2008. Cortical enlargement in autism is associated with a functional VNTR in the monoamine oxidase A gene. Am J Med Genet B Neuropsychiatr Genet 147B:1145–1151.
16. Denney RM, Koch H, Craig IW. 1999. Association between monoamine oxidase A activity in human male skin fibroblasts and genotype of the MAOA promoter-associated variable number tandem repeat. Hum Genet 105:542–551.
17. Deth R, Muratore C, Benzecry J, Power-Charnitsky VA, Waly M. 2008. How environmental and genetic factors combine to cause autism: a redox/methylation hypothesis. Neurotoxicology 29:190–201.
18. Fatemi SH, Aldinger KA, Ashwood P, Bauman ML, Blaha CD, Blatt GJ, Chauhan A, Chauhan V, Dager SR, Dickson PE, et al. 2012. Consensus paper: pathological role of the cerebellum in autism. Cerebellum 11:777–807.
19. Gu F, Chauhan V, Chauhan A. 2013a. Impaired synthesis and antioxidant defense of glutathione in the cerebellum of autistic subjects: alterations in the activities and protein expression of glutathione-related enzymes. Free Radic Biol Med 65:488–496.
20. Gu F, Chauhan V, Kaur K, Brown WT, Lafauci G, Wegiel J, Chauhan A. 2013b. Alterations in mitochondrial DNA copy number and the activities of electron transport chain complexes and pyruvate dehydrogenase in the frontal cortex from subjects with autism. Transl Psychiatry 3:e299.
21. Gu F, Chauhan V, Chauhan A. 2015. Glutathione redox imbalance in brain disorders. Curr Opin Clin Nutr Metab Care 18:89–95.
22. Gulyas B, Pavlova E, Kasa P, Gulya K, Bakota L, Varszegi S, Keller E, Horvath MC, Nag S, Hermecz I, et al. 2011. Activated MAO-B in the brain of Alzheimer patients, demonstrated by [11C]-L-deprenyl using whole hemisphere autoradiography. Neurochem Int 58:60–68.
23. Hallmayer J, Cleveland S, Torres A, Phillips J, Cohen B, Torigoe T, Miller J, Fedele A, Collins J, Smith K, et al. 2011. Genetic heritability and shared environmental factors among twin pairs with autism. Arch Gen Psychiatry 68:1095–1102.
24. Kern JK, Jones AM. 2006. Evidence of toxicity, oxidative stress, and neuronal insult in autism. J Toxicol Environ Health B Crit Rev 9:485–499.
25. Kim JJ, Shih JC, Chen K, Chen L, Bao S, Maren S, Anagnostaras SG, Fanselow MS, De Maeyer E, Seif I, Thompson RF. 1997. Selective enhancement of emotional, but not motor, learning in monoamine oxidase a deficient mice. Proc Natl Acad Sci USA 94:5929–5933.
26. Mallajosyula JK, Chinta SJ, Rajagopalan S, Nicholls DG, Andersen JK. 2009. Metabolic control analysis in a cellular model of elevated MAO-B: relevance to Parkinson's disease. Neurotox Res 16:186–193.
27. Markram K, Rinaldi T, La Mendola D, Sandi C, Markram H. 2008. Abnormal fear conditioning and amygdala processing in an animal model of autism. Neuropsychopharmacology 33:901–912.
28. Muller CL, Anacker AM, Veenstra-Vanderweele J. 2016. The serotonin system in autism spectrum disorder: From biomarker to animal models. Neuroscience 321:24–41.
29. O'Halloran CJ, Kinsella GJ, Storey E. 2012. The cerebellum and neuropsychological functioning: a critical review. J Clin Exp Neuropsychol 34:35–56.
30. Piton A, Poquet H, Redin C, Masurel A, Lauer J, Muller J, Thevenon J, Herenger Y, Chancenotte S, Bonnet M, et al. 2014. 20 ans après: a second mutation in MAOA identified by targeted high-throughput sequencing in a family with altered behavior and cognition. Eur J Hum Genet 22:776–783.
31. Ramsay RR. 2016. Molecular aspects of monoamine oxidase B. Prog Neuropsychopharmacol Biol Psychiatry 69:81–89.
32. Rivera M, Gutierrez B, Molina E, Torres-Gonzalez F, Bellon JA, Moreno-Kustner B, King M, Nazareth I, Martinez-Gonzalez LJ, Martinez-Espin E, et al. 2009. High-activity variants of the uMAOA polymorphism increase the risk for depression in a large primary care sample. Am J Med Genet B Neuropsychiatr Genet 150B:395–402.
33. Roohi J, Devincent CJ, Hatchwell E, Gadow KD. 2009. Association of a monoamine oxidase—a gene promoter polymorphism with ADHD and anxiety in boys with autism spectrum disorder. J Autism Dev Disord 39:67–74.
34. Rossignol DA, Frye RE. 2012a. Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis. Mol Psychiatry 17:290–314.
35. Rossignol DA, Frye RE. 2012b. A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures. Mol Psychiatry 17:389–401.
36. Sabol SZ, Hu S, Hamer D. 1998. A functional polymorphism in the monoamine oxidase A gene promoter. Hum Genet 103:273–279.
37. Saura J, Luque JM, Cesura AM, Da Prada M, Chan-Palay V, Huber G, Loffler J, Richards JG. 1994. Increased monoamine oxidase B activity in plaque-associated astrocytes of Alzheimer brains revealed by quantitative enzyme radioautography. Neuroscience 62:15–30.
38. Sears LL, Finn PR, Steinmetz JE. 1994. Abnormal classical eye-blink conditioning in autism. J Autism Dev Disord 24:737–751.
39. Shih JC. 1991. Molecular basis of human MAO A and B. Neuropsychopharmacology 4:1–7.
40. Shih JC, Chen K, Ridd MJ. 1999. Monoamine oxidase: from genes to behavior. Annu Rev Neurosci 22:197–217.
41. Singh C, Bortolato M, Bali N, Godar SC, Scott AL, Chen K, Thompson RF, Shih JC. 2013. Cognitive abnormalities and hippocampal alterations in monoamine oxidase A and B knockout mice. Proc Natl Acad Sci U S A 110:12816–12821.
42. Tassone F, Qi L, Zhang W, Hansen RL, Pessah IN, Hertz-Picciotto I. 2011. MAOA, DBH, and SLC6A4 variants in CHARGE: a case-control study of autism spectrum disorders. Autism Res 4:250–261.
43. Verma D, Chakraborti B, Karmakar A, Bandyopadhyay T, Singh AS, Sinha S, Chatterjee A, Ghosh S, Mohanakumar KP, Mukhopadhyay K, et al. 2014. Sexual dimorphic effect in the genetic association of monoamine oxidase A (MAOA) markers with autism spectrum disorder. Prog Neuropsychopharmacol Biol Psychiatry 50:11–20.
44. Wassink TH, Hazlett HC, Davis LK, Reiss AL, Piven J. 2014. Testing for association of the monoamine oxidase A promoter polymorphism with brain structure volumes in both autism and the fragile X syndrome. J Neurodev Disord 6:6.
45. Wingate M, Kirby RS, Pettygrove S, Cunniff C, Meaney F, Schulz E, Baio J. 2014. Prevalence of autism spectrum disorder among children aged 8 years—autism and developmental disabilities monitoring network, 11 sites, United States, 2010. MMWR Surveill Summ 63:1–21.
46. Wyatt RJ, Murphy DL. 1976. Low platelet monoamine oxidase activity and schizophrenia. Schizophr Bull 2:77–89.
47. Yirmiya N, Pilowsky T, Tidhar S, Nemanov L, Altmark L, Ebstein RP. 2002. Family-based and population study of a functional promoter-region monoamine oxidase A polymorphism in autism: possible association with IQ. Am J Med Genet 114:284–287.
48. Yoo HJ, Lee SK, Park M, Cho IH, Hyun SH, Lee JC, Yang SY, Kim SA. 2009. Family- and population-based association studies of monoamine oxidase A and autism spectrum disorders in Korean. Neurosci Res 63:172–176.
49. Youdim MB, Bakhle YS. Monoamine oxidase: isoforms and inhibitors in Parkinson's disease and depressive illness. 2006. Br J Pharmacol 147 Suppl 1:S287–S296.
50. Youdim MB, Riederer PF. A review of the mechanisms and role of monoamine oxidase inhibitors in Parkinson's disease. 2004. Neurology 63:S32–S35.